Navigate BioPharma Services, Inc.
Amit K Mehta is a Principal Scientist at Navigate BioPharma Services, Inc. since April 2023, previously serving as a Senior Scientist and Scientist at Fate Therapeutics Inc. from March 2018 to March 2023. Amit's research background includes a postdoctoral position at the La Jolla Institute for Allergy and Immunology from October 2009 to February 2018, focusing on the effects of TNF family members on pulmonary inflammation and asthma susceptibility. Prior experience includes a Doctoral Researcher role at the Institute of Genomics and Integrative Biology (CSIR) from October 2003 to May 2009, where Amit investigated choline as an anti-inflammatory treatment for asthma, as well as a Project Fellow developing allergenicity evaluation protocols for genetically modified foods. Amit holds a Master of Science in Biotechnology and a Bachelor of Science in Microbiology, both from Devi Ahilya Vishwavidyalaya (DAVV).
This person is not in any offices
Navigate BioPharma Services, Inc.
Navigate BioPharma is a specialty laboratory offering high quality, innovative and differentiated precision medicine solutions for drug development and diagnostic applications. We enable innovative treatments through integrated laboratory services to improve and expedite the clinical trial process—aiming to increase your probability of success. We take on complex issues, utilizing our deep scientific knowledge, diversity of experience, adaptability and regulatory success to design customized offerings that help bring new treatments to market faster. Our deep scientific knowledge in diagnosis, disease monitoring and the #immunotherapy field—including #cart #celltherapy— gets our clients the data they need. With end-to-end services customized for each client, we take a consultative and comprehensive approach to deliver accurate and actionable information in an effort to improve treatment outlook for clinical trial subjects. #bioanalysis #bioanalytical #biomarker #immunooncology #biopharma #drugdevelopment *Navigate BioPharma is an independent subsidiary of Novartis.